Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 5475
  • 5476
  • 5477
  • …
  • ›
  • »

2026-04-07

SHIMAO GROUP 1Q Contracted Sales RMB4.523 Billion, Down 36% YoY

2026-04-07

Revival Gold Inc.: Revival Gold Drills 2.8 g/t gold over 74 meters Including 8.0 g/t over 12 meters at the Mercur Gold Project in Utah

2026-04-07

KIA SPORTAGE HYBRID NAMED IN CARS.COM′S 2026 BEST VALUE NEW CARS

2026-04-07

Randy Anaya Brings 65-Agent Equity Realty Group to The Real Brokerage

2026-04-07

2026 Mazda3 2.5 S Sedan Recognized in Cars.com Best Value New Car

2026-04-07

W. P. Carey to Release First Quarter 2026 Financial Results on Tuesday, April 28, 2026

2026-04-07

Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference

2026-04-07

Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption

2026-04-07

CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting

2026-04-07

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

2026-04-07

Invitation to presentation of Dustin′s interim report on April 15

2026-04-07

Avrupa Adopts Semi-Annual Financial Reporting

  • «
  • ‹
  • …
  • 5475
  • 5476
  • 5477
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 03/Jul/2026 17:19:59
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies